Body Mass Index Predicts Decline in Executive Function in Bipolar Disorder: Preliminary Data of a 12-Month Follow-up Study.


Journal

Neuropsychobiology
ISSN: 1423-0224
Titre abrégé: Neuropsychobiology
Pays: Switzerland
ID NLM: 7512895

Informations de publication

Date de publication:
2021
Historique:
received: 30 09 2019
accepted: 05 01 2020
pubmed: 27 5 2020
medline: 21 10 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

Obesity and associated risk factors have been linked to cognitive decline before. In the present study, we evaluated potential cumulative negative effects of overweight and obesity on cognitive performance in euthymic patients with bipolar disorder (BD) in a longitudinal design. Neurocognitive measures (California Verbal Learning Test, Trail Making Test [TMT] A/B, Digit-Symbol-Test, Digit-Span, d2 Test), anthropometrics (e.g., body mass index [BMI]), and clinical ratings (Hamilton Depression Scale, Young Mania Rating Scale) were collected over a 12-month observation period. Follow-up data of 38 patients with BD (mean age 40 years; 15 males, 23 females) were available. High baseline BMI predicted a decrease in the patient's performance in the Digit-Span backwards task measuring working memory performance. In contrast, cognitive performance was not predicted by increases in BMI at follow-up. Normal weight bipolar patients (n = 19) improved their performance on the TMT B, measuring cognitive flexibility and executive functioning, within 1 year, while overweight bipolar patients (n = 19) showed no change in this task. The results suggest that overweight can predict cognitive performance changes over 12 months.

Identifiants

pubmed: 32454501
pii: 000505784
doi: 10.1159/000505784
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Nina Dalkner (N)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Susanne Bengesser (S)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria, susanne.bengesser@medunigraz.at.

Armin Birner (A)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Alexandra Rieger (A)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Julia Seebauer (J)

Department of Biological Psychology, University of Graz, Graz, Austria.

Martina Platzer (M)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Carlo Hamm (C)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Alexander Maget (A)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Robert Queissner (R)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

René Pilz (R)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Frederike T Fellendorf (FT)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Bernd Reininghaus (B)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Martin T Strassnig (MT)

Department of Integrated Medical Science, Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA.

Hans-Peter Kapfhammer (HP)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Elisabeth M Weiss (EM)

Department of Biological Psychology, University of Graz, Graz, Austria.
Department of Psychology, University of Innsbruck, Clinical Psychology, Innsbruck, Austria.

Eva Z Reininghaus (EZ)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH